Xeris Biopharma Holdings, Inc. XERS
Set alert
10.17 USD -0.54 -5.04%
At close · Nov 2
10.14 -0.03 -0.29%
After hours · Nov 2, 4:00 PM ET
10.08 Day range 10.72
5.25 52-week range 11.42
- YTD
- +29.55%
- 1 year
- +4.85%
- Open
- 10.71
- Prev close
- 10.71
- Mkt cap
- 1.85B
- Vol
- 2.31M
- Avg vol
- 2.35M
- EPS
- -0.10
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 10.08
- High
- 10.72
- Forward P/E
- 51.71
- Beta
- 0.84
- Short ratio
- 2.46
- Inst. own
- 61.87%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 9.31
- 200-d avg
- 7.50
- 1y target
- 12.86
5D chart
Signals (100)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 3:55 PM | 15 hours ago |
| MACD: Sell Signal | Nov 2, 3:55 PM | 15 hours ago |
| SMA: Bearish | Nov 2, 3:50 PM | 15 hours ago |
| SMA: Bullish | Nov 2, 2:40 PM | 16 hours ago |
| MACD: Buy Signal | Nov 2, 2:10 PM | 16 hours ago |
| SMA: Bearish | Nov 2, 1:10 PM | 17 hours ago |
| MACD: Sell Signal | Nov 2, 1:10 PM | 17 hours ago |
| SMA: Bearish | Nov 2, 1:00 PM | 18 hours ago |
| SMA: Bullish | Nov 2, 12:45 PM | 18 hours ago |
| SMA: Bullish | Nov 2, 11:50 AM | 19 hours ago |
| SMA: Bullish | Nov 2, 11:05 AM | 19 hours ago |
| MACD: Buy Signal | Nov 2, 11:05 AM | 19 hours ago |
| SMA: Bearish | Nov 2, 10:50 AM | 20 hours ago |
| SMA: Bullish | Nov 2, 10:45 AM | 20 hours ago |
| RSI: Oversold | Nov 2, 10:40 AM | 20 hours ago |
| RSI: Oversold | Nov 2, 9:40 AM | 21 hours ago |
| SMA: Bearish | Nov 2, 9:30 AM | 21 hours ago |
| SMA: Bearish | Nov 2, 9:30 AM | 21 hours ago |
| MACD: Sell Signal | Nov 2, 9:30 AM | 21 hours ago |
| RSI: Overbought | Oct 30, 3:55 PM | 3 days ago |
Newest 20 of 100.
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 291.85M | 203.07M | 163.91M | 110.25M | 49.59M | |
| 249.28M | 166.24M | 135.27M | 87.61M | 36.27M | |
| 24.90M | -33.65M | -44.01M | -81.94M | -115.16M | |
| 554.00K | -54.84M | -62.26M | -94.66M | -122.72M |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 111.04M | 71.62M | 67.45M | 121.97M | 67.27M | |
| 383.53M | 323.06M | 322.60M | 344.52M | 304.36M | |
| 369.84M | 352.68M | 329.38M | 299.33M | 209.13M | |
| 258.10M | 271.45M | 229.19M | 198.06M | 88.07M | |
| 13.69M | -29.61M | -6.78M | 45.19M | 95.23M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 28.63M | -36.98M | -47.02M | -102.89M | -95.53M | |
| -696.00K | 4.88M | -6.00M | 34.46M | 97.96M | |
| 11.39M | 36.17M | -1.61M | 127.47M | 27.25M | |
| -696.00K | -868.00K | -2.26M | -524.00K | -1.08M | |
| 39.32M | 4.07M | -54.64M | 59.04M | 29.67M |